# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Constellation Brands' stock rises despite revising FY25 EPS and sales forecasts and anticipating a significant non-cash goo...
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $255 to $265.
Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.
JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.
Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $260 price target.
Fiscal 2025 Outlook Reiterated
Steris (NYSE:STE) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.98 by 2.53 per...